Extended knowledge of C18H30O2

If you are interested in 506-26-3, you can contact me at any time and look forward to more communication. Product Details of 506-26-3.

In an article, author is Nagai, Junko, once mentioned the application of 506-26-3, Product Details of 506-26-3, Name is (6Z,9Z,12Z)-Octadeca-6,9,12-trienoic acid, molecular formula is C18H30O2, molecular weight is 278.43, MDL number is MFCD00065718, category is bromides-buliding-blocks. Now introduce a scientific discovery about this category.

Quantitative Structure-Cytotoxicity Relationship of 2-Arylazolylchromones and 2-Triazolylchromones

Background/Aim: 4H-1-Benzopyran-4-one (chromone), present in various flavonoids as a backbone structure, has been used for the synthesis of anticancer drugs. The study aimed at investigating the cytotoxicity of eight 2-arylazolylchromones and twelve 2-triazolylchromones against four human oral squamous cell carcinoma (OSCC) cell lines and three human normal mesenchymal oral cells, and then performed a quantitative structure-activity relationship (QSAR) analysis. Materials and Methods: Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide method. The distribution of cells to various phases of cell cycle was determined by cell cycle analysis. A total of 3,218 physicochemical, structural and quantum chemical features were calculated for QSAR analysis from the most stabilized structure optimized using CORINA. Results: 2-[4-(4-fluorophenyl)-1H-imidazol-1-yl]-4H-1-benzopyran-4-one [6] had the highest tumor-specificity (TS), comparable with that of 5-flurouracil (5-FU) and doxorubicin, inducing cytostatic growth inhibition, accumulation of G(2)+M phase cells with no cells in the G(1) phase. All eight 2-triazolylchromones showed much lower tumor-specificity, confirming our previous finding. Tumor-specificity was also correlated with 3D shape, topological shape, size, ionization potential, and the presence of more than two aromatic rings in the molecule and imidazole ring in the nitrogen-containing heterocyclic ring. Conclusion: [6] can be a lead compound for designing anticancer drugs.

If you are interested in 506-26-3, you can contact me at any time and look forward to more communication. Product Details of 506-26-3.